Oligometastases and Oligo-recurrence: The New Era of Cancer Therapy
Top Cited Papers
Open Access
- 4 January 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 40 (2) , 107-111
- https://doi.org/10.1093/jjco/hyp167
Abstract
Recurrence or metastasis of cancer has been considered to occur in the last stage of the patient's life. However, the new notions of oligometastases and oligo-recurrence have been proposed and the paradigm shift in the conceptualization of cancer metastasis or cancer recurrence. Oligometastases is the state in which the patient shows distant relapse in only a limited number of regions. Local therapy such as surgery, radiotherapy and radiofrequency ablation for the relapsed sites could thus improve patient's survival. On the other hand, oligo-recurrence is a notion similar to oligometastases. However, the conditions of oligo-recurrence has a primary site of the cancer controlled, meaning that all gross recurrent or metastatic sites could be treated using local therapy.Keywords
This publication has 26 references indexed in Scilit:
- Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung MetastasesJournal of Clinical Oncology, 2009
- Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver MetastasesJournal of Clinical Oncology, 2009
- Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapyBreast Cancer Research and Treatment, 2008
- Local Therapy and Survival in Breast CancerNew England Journal of Medicine, 2007
- Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: A multi-institutional studyGynecologic Oncology, 2006
- Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii studyActa Oncologica, 2006
- Interim analysis of a prospective phase I/II trial of SBRT for liver metastasesActa Oncologica, 2006
- Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialThe Lancet, 2004
- Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapyInternational Journal of Gynecologic Cancer, 2003
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsPublished by Elsevier ,1997